OCT 24, 2016 5:50 PM PDT

Mechanism Underlying Type I Diabetes Identified as Drug Target

WRITTEN BY: Carmen Leitch
New research done at Helmholtz Zentrum München, in partnership with the German Center for Diabetes Research and colleagues at Technical University of Munich has revealed more about the mechanism underlying type I diabetes. The work may open up a new avenue of treatment for people afflicted with the disorder.
 

 
In type I diabetes, the body’s immune system attacks cells of the pancreas, called beta cells. Beta cells are responsible for producing insulin, so the body the loss of those cells means there isn’t enough insulin. The death of beta cells cannot be ameliorated, resulting in insulin deficiency and elevated blood glucose levels. Patients have to monitor their insulin and carefully maintain the level in their bodies. If you'd like to know more about the disease, watch the video above.
 
It’s still unclear exactly why the immune system launches an attack on the beta cells. The new work utilized a biobank of blood samples, established by Professor Anette-Gabriele Ziegler, the director of the Institute of Diabetes Research at Helmholtz Zentrum München, to investigate this issue. The researchers have shed some light on the mechanism behind the immune response. "For the first time, we were able to show that in the affected children an increased number of specific immune cells are found in the blood at the beginning of the autoimmune response," explained by Dr. Carolin Daniel of the IDF.
 
The appearance of antibodies against pancreatic islets is indicative of the onset of type I diabetes. Those antibodies are produced by white blood cells of the immune system, B lymphocytes, in conjunction with T follicular helper (TFH) cells. Indeed, the increased levels of those cells were confirmed in children that had recently experienced islet cell autoimmunity, an early stage of type I disease.
 
In the Proceedings of the National Academy of Sciences, Daniel and co-authors report that precursors to an enrichment of a type of those TFH cells correlates with an increase in a particular type of microRNA – miRNA92a. miRNAs do not code for protein but are known to play an influential role in the regulation of cellular processes such as immune activation.
 
Treatment with an antagomir directed against miR92a results in reduced attacks of immune cells (green) on the insulin (white) producing beta cells directly in the pancreas. Moreover, the treatment leads to more regulatory T cells (red) able to protect the beta cells./ Credit: Helmholtz Zentrum München
 
"Our analyses showed that a molecule called miRNA92a triggers a chain of molecular events, which ultimately leads to the increase in these immune cells," explained IDF doctoral student Isabelle Serr. "In particular, during this process, miRNA92a interferes with the formation of important signaling proteins such as KLF2 and PTEN."
 
The researchers decided to exploit this previously unknown pathway as a drug target. They tested the effect of a so-called antagomir, one that binds to miRNA92a molecules in particular to stop their effect. There was success in their experimental model; its use resulted in a significantly reduced autoimmune response.
 
"The targeted inhibition of miRNA92a or the downstream signaling pathway could open up new possibilities for the prevention of type 1 diabetes," said Ziegler. "Furthermore, the insulin-specific TFH cells could serve as biomarkers to determine the treatment success of the insulin vaccinations we perform."
 
If you’d like to know more about miRNAs, watch the lecture below from David Bartel of MIT.
 

 
Sources: Science Daily via Helmholtz Zentrum Muenchen - German Research Centre for Environmental Health, PNAS
 
About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 14, 2020
Health & Medicine
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
SEP 14, 2020
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
As the SARS-CoV-2 pandemic continues to rage across the United States and around the globe, the demand for COVID-19 test ...
OCT 05, 2020
Cell & Molecular Biology
Gaining Insight Into the Connection Between Depression and Stress
OCT 05, 2020
Gaining Insight Into the Connection Between Depression and Stress
Depression is a common mental illness, and stress is known to be an environmental influence that can increase the risk o ...
OCT 13, 2020
Clinical & Molecular DX
Test for Diabetes Checks If the Liver Is Responding
OCT 13, 2020
Test for Diabetes Checks If the Liver Is Responding
Glucagon is a hormone that prevents blood glucose levels from dropping too low by stimulating the liver to convert store ...
NOV 09, 2020
Cell & Molecular Biology
The Science Behind Wine Fraud Prevention
NOV 09, 2020
The Science Behind Wine Fraud Prevention
Wine comes in a wide range of flavors and prices. Wine fraud, in which cheaply produced wine is passed off as the expens ...
NOV 19, 2020
Cardiology
Examining a Possible Link Between Atherosclerosis and Inflammation
NOV 19, 2020
Examining a Possible Link Between Atherosclerosis and Inflammation
The immune system’s primary duty is to protect the body from dangerous invaders. Many don’t know that it als ...
NOV 30, 2020
Genetics & Genomics
Green Genetic Technology Can Help Feed the World
NOV 30, 2020
Green Genetic Technology Can Help Feed the World
In the latter half of the last century, agriculture underwent a technological revolution that enabled farmers to create ...
Loading Comments...